Two Sigma Securities, LLC United Therapeutics Corp Call Options Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.62 Million - $1.92 Million	7,700 New	7,700 $1.77 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $593,096 - $695,072	2,800 Added 121.74%	5,100 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $61,557 - $69,897	300 Added 15.0%	2,300 $507,000
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $42,598 - $55,234	-200 Reduced 9.09%	2,000 $447,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $453,090 - $616,946	2,200 New	2,200 $611,000

Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $258,604 - $410,754	-3,400 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $364,310 - $431,256	3,400 New	3,400 $399,000

561

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.